NUS Spinout Endofotonics Launches with New Cancer Diagnosis Technology

 

Using NGS as CDx Will Require Paradigm Shift, Regulatory Changes, According to Experts at AACR

 

Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing

 

Physicians' Plans to Implement NGS-based Tumor Tests Vary Widely, Study Finds

 

Last Week's Clinical Sequencing Papers of Note

 

People in the News: Jill Hagenkord, Robert Daber, Qingson Zhu

 

New Products: Genewiz's PGxOne

 

Qiagen Consolidates, Invests $10M in Maryland Facilities

 

Affymetrix, CollabRx Partner to Integrate Genomics Analysis Tools

 

Abbott's Q1 MDx Sales Rise 5 Percent